Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2022 Apr-Jun;15(2):168-174.
doi: 10.4103/JCAS.JCAS_68_21.

Incobotulinum Toxin A with a One-year Long-lasting Effect for Trapezius Contouring and Superior Efficacy for the Treatment of Trapezius Myalgia

Napamon Supornpun  1 , Paisal Rummaneethorn  1 , Thamthiwat Nararatwanchai  1 , Tawee Saiwichai  2 , Sirinthip Chaichalotornkul  1
Affiliations

Incobotulinum Toxin A with a One-year Long-lasting Effect for Trapezius Contouring and Superior Efficacy for the Treatment of Trapezius Myalgia

Napamon Supornpun et al. J Cutan Aesthet Surg. 2022 Apr-Jun.

Abstract

Context: Based on various Botulinum toxin A products, reports of the lower efficacy of Incobotulinum toxin A compared with Onabotulinum toxin A for muscle contouring were observed. In addition, complications of trapezius myalgia and shoulder contouring treatment from malpractice have been reported.

Aims: The study aimed at comparing the efficacy between Incobotulinum toxin A and Onabotulinum toxin A; research was conducted on a safe treatment technique for trapezius hypertrophy and trapezius myalgia.

Materials and methods: A split-shoulder, double-blind, randomized controlled trial was performed. Twenty volunteers with trapezius hypertrophy and trapezius myalgia were randomly injected with 30 units of Incobotulinum toxin A and Onabotulinum toxin A in each trapezius muscle guided by ultrasound.

Results: The trapezius thickness among those receiving treatment with Onabotulinum toxin A and Incobotulinum toxin A on day 60 was 7.35 ± 1.11 and 7.33 ± 1.21 mm, respectively, which did not portray a significant difference (P = 0.991). Compared with the muscle size from day 60 to one year, the size of the trapezius muscle that had been treated by Onabotulinum toxin type A regained a significantly larger size compared with that treated by Incobotulinum toxin A (P = 0.027). On comparing the size of the trapezius muscle treated by Incobotulinum toxin A between one year and day 0, it was observed that the trapezius thickness at one year had significantly decreased (P < 0.001). On comparing the pain score from day 60 to day 0, it was observed that the pain scores of trapezius myalgia treated by Onabotulinum toxin A and Incobotulinum toxin A significantly differed (P = 0.003).

Conclusions: Incobotulinum toxin A had the same efficacy but a longer lasting effect for the trapezius size contouring and a higher efficacy for trapezius myalgia treatment compared with Onabotulinum toxin A.

Keywords: Incobotulinum toxin A; Onabotulinum toxin A; trapezius hypertrophy; trapezius myalgia; ultrasound-guided injection.

PubMed Disclaimer

Conflict of interest statement

There are no conflicts of interest.

Figures

Figure 1
Figure 1
Six points of injection in the middle part of an imaginary line from the cervical spine level 7 to the acromion process
Figure 2
Figure 2
Ultrasound-guided injection technique
Figure 3
Figure 3
Before treatment
Figure 4
Figure 4
After treatment
Figure 5
Figure 5
Trapezius thickness from ultrasonography: (A) before; (B) after
Figure 6
Figure 6
Comparison of trapezius thickness within the group at different points of time: The different letters indicate significance
Figure 7
Figure 7
Pair differences of mean pain scores in trapezius myalgia (* indicating a significant difference, P = 0.003)
See this image and copyright information in PMC

Similar articles

See all similar articles

Cited by

References

    1. De Meulemeester K, Calders P, De Pauw R, Grymonpon I, Govaerts A, Cagnie B. Morphological and physiological differences in the upper trapezius muscle in patients with work-related trapezius myalgia compared to healthy controls: A systematic review. Musculoskelet Sci Pract. 2017;29:43–51. - PubMed
    1. Larsson B, Søgaard K, Rosendal L. Work-related neck/shoulder pain: A review on the magnitude, risk factors, biochemical characteristics, clinical picture, and preventive interventions. Best Pract Res: Clin Rheumatol. 2007;21:447–63. - PubMed
    1. O’Sullivan C, Meaney J, Boyle G, Gormley J, Stokes M. The validity of rehabilitative ultrasound imaging for measurement of trapezius muscle thickness. Man Ther. 2009;14:572–8. - PubMed
    1. Kwanchuay P, Petchnumsin T, Yiemsiri P, Pasuk N, Srikanok W, Hathaiareerug C. Efficacy and safety of single botulinum toxin type A (Botox®) injection for relief of upper trapezius myofascial trigger point: A randomised, double blind, placebo control study. J Med Assoc Thai. 2015;98:1231–6. - PubMed
    1. Dashtipour K, Chen JJ, Walker HW, Lee MY. Systematic literature review of abobotulinum toxin A in clinical trials for adult upper limb spasticity. Am J Phys Med Rehabil. 2015;94:229–38. - PMC - PubMed